From the *Department of Pediatrics, Hematology and Oncology
†Department of Microbiology, Collegium Medicum, Nicolaus Copernicus University Torun, Bydgoszcz, Poland
‡Department of Oncology
§Department of Microbiology, Children’s Memorial Health Institute, Warsaw, Poland
¶Department of Pediatric Oncology and Hematology, University Children’s Hospital, Jagiellonian University, Collegium Medicum
‖Department of Microbiology, University Children’s Hospital, Krakow, Poland
**Department of Pediatric Stem Cell Transplantation, Hematology and Oncology, Medical University, Wroclaw, Poland
††Department of Pediatric Oncology, Hematology and Transplantology, University of Medical Sciences, Poznan, Poland
‡‡Department of Pediatrics, Hematology and Oncology, Medical University, Gdansk, Poland
§§Department of Pediatric Oncology and Hematology, Medical University, Bialystok, Poland
¶¶Department of Pediatrics, Pediatric Oncology and Immunology
‖‖Department of Pediatrics, Pediatric Hematooncology and Gastroenterology, Pomeranian Medical University, Szczecin, Poland
***Department of Pediatrics, Hematology and Oncology, Medical University, Lodz, Poland
†††Division of Pediatric Hematology and Oncology, Chorzow City Hospital, Chorzow, Poland
‡‡‡Division of Pediatric Hematology and Oncology, Children Hospital, Olsztyn, Poland
§§§Division of Pediatric Oncology, Hematology and Chemotherapy, Department of Pediatric, Silesian Medical University, Katowice, Poland
¶¶¶Department of Pediatric Oncohematology, Medical Faculty University of Rzeszow, Clinical Provincial Hospital No. 2, Rzeszow, Poland
‖‖‖Department of Pediatric Hematology and Oncology, Medical University, Warszawa, Poland
****Department of Pediatric Hematology and Oncology, Silesian Medical University, Zabrze, Poland
††††Division of Pediatric Hematology and Oncology, Children Hospital, Kielce, Poland
‡‡‡‡Department of Pediatric Hematology, Oncology and Transplantology, Medical University, Lublin, Poland
§§§§ Stem Cell Transplant Center, University Children’s Hospital, Department of Clinical Immunology and Transplantology, Jagiellonian University Collegium Medicum, Krakow, Poland.
Accepted for publication June 13, 2022
The authors have no funding or conflicts of interest to disclose.
J.S., K.C. and M.R.-P. involved in the conception and design of the study. K.C., M.D., P.Z.-W., O.G.-K., A.G., Z.M., K.S., L.C., I.Z., M.S.-B., J.F., O.Z.-S., E.B., N.I.-J., M.P., P.W., M.B., F.P., Z.G., W.B., W.S., J.M., A.S.-B., L.H., R.T., A.U.-D., A.Z.-P. and J.G. involved in collection of data. J.S. and M.R.-P. involved in statistics and interpretation of data. K.C., M.D. and M.R.-P. involved in drafting the article. J.S., K.C. and M.R.-P. involved in critical review. J.S. and M.R.-P. involved in final approval.
Address for correspondence: Monika Richert-Przygonska, MD, PhD, Department of Pediatrics, Hematology and Oncology, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, ul. Sklodowskiej-Curie 9, 85-094 Bydgoszcz, Poland. E-mail: [email protected].
